LatestEndometriosis often goes undiagnosed for years. Here's what you need to know
Cannabis

Catalonia Records Record 308 Drug-Related Deaths in 2024, Highlighting Need for Harm Reduction

Redacción
Catalonia Records Record 308 Drug-Related Deaths in 2024, Highlighting Need for Harm Reduction
Summary

Catalonia documented 308 deaths from acute drug reactions in 2024, marking the highest figure since tracking began in 2017. Over 80% of fatalities involved polysubstance use, with 68% occurring in homes, underscoring the critical need for expanded prevention policies. Public health experts emphasize that harm reduction strategies and increased access to naloxone are essential interventions to prevent overdose deaths. This alarming trend reflects the complex challenges of substance use disorders and highlights the importance of community-based support and emergency response protocols for individuals struggling with addiction.

Originally published on

Revista Cáñamo

By Redacción

Read full article(opens in new tab)

Fetched: September 4, 2026 at 10:03 AM

Related News

More news you might be interested in

View all
CBDA Shows Promise in Protecting Brain from High-Fat Diet Damage
Cannabis
Alzheimer's DiseaseDiabetes

CBDA Shows Promise in Protecting Brain from High-Fat Diet Damage

Preclinical research from Polish universities published in Inflammopharmacology reveals that CBDA (cannabidiolic acid), a non-decarboxylated cannabis component, significantly reduces neuroinflammation markers and prevents pathological lipid accumulation in the brain cortex. The study, conducted in rodents on high-fat diets, demonstrates that controlled CBDA administration restores insulin signaling in neurons, offering potential neuroprotective benefits. While these findings are physiologically significant, they remain preliminary and await validation in human clinical trials to determine therapeutic applications for diet-related neurological damage.

yesterday
Soft Secrets (Español)
North Carolina Legislators Navigate Marijuana and Hemp Regulation Amid Federal Uncertainty
Cannabis

North Carolina Legislators Navigate Marijuana and Hemp Regulation Amid Federal Uncertainty

North Carolina lawmakers face critical decisions regarding intoxicating hemp product regulation when the state legislature reconvenes in November, as federal cannabis policy remains uncertain. State officials have expressed caution about legalization prospects, indicating that while marijuana legalization could occur, it remains far from guaranteed. The regulatory landscape for hemp-derived products must be addressed regardless of broader legalization efforts, requiring clear guidelines to protect consumers. This situation reflects the broader national challenge of aligning state policies with evolving federal frameworks governing cannabis and cannabinoid products.

yesterday
Marijuana Moment
Beware of the Chads: How Institutional Money Is Reshaping the Cannabis Industry
Cannabis

Beware of the Chads: How Institutional Money Is Reshaping the Cannabis Industry

Industry veteran Berner warns of a new wave of institutional investors entering the cannabis market without genuine understanding of the plant or its therapeutic potential. The influx of venture capital and corporate money has historically displaced founders and changed company cultures at major firms like MedMen, Flow Kana, Canopy, and High Times. Understanding the difference between investor-driven and founder-led cannabis companies matters for patients seeking quality medical cannabis products and reliable therapeutic guidance. Rolando García explores how term sheets and institutional agendas have reshaped the industry and identifies strategies that founders have used to maintain control and preserve their original missions.

yesterday
High Times
MJBizDaily
Cannabis

Arizona Cannabis Testing Lab Continues Rule Violations Despite Previous Fines

An Arizona cannabis testing laboratory has continued violating state regulations despite being fined previously, according to recent state inspection results. The facility's ongoing noncompliance raises serious concerns about product safety and accuracy of cannabinoid testing for consumers. Testing labs play a critical role in verifying THC/CBD potency and screening for contaminants like pesticides and microbial pathogens that could harm patients relying on medical cannabis for therapeutic purposes. The laboratory's continued operation despite violations highlights gaps in regulatory enforcement within Arizona's cannabis industry. This situation underscores the importance of robust oversight to protect patients who depend on reliable testing data for safe medical cannabis use.

2 days ago
MJBizDaily